ResMed Inc.NYSE: RMD

ResMed: Fiscal Q4 Earnings Snapshot

· Issued by ResMed Inc.

Summary by 6ix AI

ResMed Inc., a San Diego-based maker of medical products for respiratory disorders, reported fiscal fourth-quarter net income of $383.4 million, or $2.64 per share, on revenue of $1.46 billion.

Key details

  • Adjusted earnings, which exclude one-time gains and costs, were $2.95 per share for the fiscal fourth quarter, above the average estimate of $2.90 per share from six analysts surveyed by Zacks Investment Research.
  • Fiscal fourth-quarter revenue of $1.46 billion met Wall Street forecasts.
  • For the full fiscal year, ResMed reported profit of $1.52 billion, or $10.43 per share, on revenue of $5.65 billion.

6ix AI wrote this summary from the release below and checked it against the release.

SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal fourth-quarter net income of $383.4 million.

On a per-share basis, the San Diego-based company said it had profit of $2.64. Earnings, adjusted for one-time gains and costs, came to $2.95 per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $2.90 per share.

The maker of medical products for respiratory disorders posted revenue of $1.46 billion in the period, which met Street forecasts.

For the year, the company reported profit of $1.52 billion, or $10.43 per share. Revenue was reported as $5.65 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RMD at https://www.zacks.com/ap/RMD

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News

ResMed Inc. on 6ix

In the deck

Earlier from ResMed

Later from ResMed

All ResMed news releases